Jonathan Javitt
Chairman and CEO
Analyst — Chief Scientist
Chairman
Board Member
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2023 | NRX Pharmaceuticals, Inc. (NRXP) | Chairman and Chief Scientist | $602,755 | $630,198 |
| 2022 | NRX Pharmaceuticals, Inc. (NRXP) | Chairman and Chief Scientist | $867,446 | $873,696 |
Executive changes
Earnings-call appearances
-
Q1 2026 Financial Results Conference Call2026-05-18
NRX Pharmaceuticals, Inc. (NRXP)
-
Q4 2025 Financial Results Conference Call2026-03-24
NRX Pharmaceuticals, Inc. (NRXP)
-
NRX Pharmaceuticals, Inc. Q4 FY2025 Earnings Call2025-12-31
NRX Pharmaceuticals, Inc. (NRXP)
-
NRX Pharmaceuticals, Inc. Q3 FY2025 Earnings Call2025-11-17
NRX Pharmaceuticals, Inc. (NRXP)
-
NRX Pharmaceuticals, Inc. Q2 FY2025 Earnings Call2025-08-20
NRX Pharmaceuticals, Inc. (NRXP)
-
NRX Pharmaceuticals, Inc. Q1 FY2025 Earnings Call2025-05-31
NRX Pharmaceuticals, Inc. (NRXP)
-
NRX Pharmaceuticals, Inc. Q4 FY2024 Earnings Call2025-03-17
NRX Pharmaceuticals, Inc. (NRXP)
-
NRX Pharmaceuticals, Inc. Q3 FY2024 Earnings Call2024-11-15
NRX Pharmaceuticals, Inc. (NRXP)
-
NRX Pharmaceuticals, Inc. Q2 FY2024 Earnings Call2024-08-15
NRX Pharmaceuticals, Inc. (NRXP)
-
NRX Pharmaceuticals, Inc. Q1 FY2024 Earnings Call2024-04-02
NRX Pharmaceuticals, Inc. (NRXP)
-
NRX Pharmaceuticals, Inc. Q4 FY2023 Earnings Call2023-12-31
NRX Pharmaceuticals, Inc. (NRXP)
-
NRX Pharmaceuticals, Inc. Q3 FY2023 Earnings Call2023-11-14
NRX Pharmaceuticals, Inc. (NRXP)
-
NRX Pharmaceuticals, Inc. Q2 FY2023 Earnings Call2023-06-30
NRX Pharmaceuticals, Inc. (NRXP)
-
NRX Pharmaceuticals, Inc. Q4 FY2022 Earnings Call2023-03-31
NRX Pharmaceuticals, Inc. (NRXP)
-
NRX Pharmaceuticals, Inc. Q1 FY2023 Earnings Call2023-03-31
NRX Pharmaceuticals, Inc. (NRXP)
-
NRX Pharmaceuticals, Inc. Q3 FY2022 Earnings Call2022-11-14
NRX Pharmaceuticals, Inc. (NRXP)
-
NRX Pharmaceuticals, Inc. Q3 FY2021 Earnings Call2021-09-30
NRX Pharmaceuticals, Inc. (NRXP)
-
NRX Pharmaceuticals, Inc. Q2 FY2021 Earnings Call2021-06-30
NRX Pharmaceuticals, Inc. (NRXP)